17 research outputs found

    Human papilloma virus and breast cancer: The role of inflammation and viral expressed proteins

    Get PDF
    Background: Breast cancer is currently the most common neoplasm diagnosed in women globally. There is a growing body of evidence to suggest that human papillomavirus (HPV) infection may play a key role in invasiveness of breast cancer. The aim of this study was to determine the presence of HPV in patients with breast cancer and its possible association with cancer progression. Methods: Breast specimens were collected from 72 patients with breast cancer and 31 healthy controls. The presence of HPV was investigated by polymerase chain reaction (PCR) and genotyping was performed for positive cases. We also evaluated the viral factors such as E6, E2, and E7 in HPV positive cases. Enzyme-linked immunosorbent assay (ELISA (and Real-time PCR techniques were used to measure the expression level of anti-carcinogenic genes, such as p53, retinoblastoma (RB), breast and ovarian cancer susceptibility gene (BRCA1, BRCA2) and inflammatory cytokines, including tumor necrosis factor α (TNF-α), transforming growth factor β (TGF-β), nuclear factor-kB (NF-kB), and different interleukins ILs (IL-1,IL6, and IL-17). Results: The HPV DNA was detected in 48.6% of breast cancer samples, whereas only 16.1% of controls were positive for HPV. We observed statistically significant differences between breast cancer patients and HPV presence (P = 0.003). HPV type 18 was the most prevalent virus genotype in patients. The expression of P53, RB, BRCA1, and BRCA2 were decreased in patients with HPV-positive breast cancer as compared to HPV-negative breast cancer and healthy controls. (All P-values were less than 0.05). The presence of the HPV was associated with increased inflammatory cytokines (IL-1, IL-6, IL-17, TGF-β, TNF-α, and NF-kB) and tumor progression. Conclusion: The present study demonstrated that HPV infection may implicate in the development of some types of breast cancer. © 2019 The Author(s)

    Human papilloma virus and breast cancer: The role of inflammation and viral expressed proteins

    Get PDF
    Background: Breast cancer is currently the most common neoplasm diagnosed in women globally. There is a growing body of evidence to suggest that human papillomavirus (HPV) infection may play a key role in invasiveness of breast cancer. The aim of this study was to determine the presence of HPV in patients with breast cancer and its possible association with cancer progression. Methods: Breast specimens were collected from 72 patients with breast cancer and 31 healthy controls. The presence of HPV was investigated by polymerase chain reaction (PCR) and genotyping was performed for positive cases. We also evaluated the viral factors such as E6, E2, and E7 in HPV positive cases. Enzyme-linked immunosorbent assay (ELISA (and Real-time PCR techniques were used to measure the expression level of anti-carcinogenic genes, such as p53, retinoblastoma (RB), breast and ovarian cancer susceptibility gene (BRCA1, BRCA2) and inflammatory cytokines, including tumor necrosis factor α (TNF-α), transforming growth factor β (TGF-β), nuclear factor-kB (NF-kB), and different interleukins [ILs] (IL-1,IL6, and IL-17). Results: The HPV DNA was detected in 48.6% of breast cancer samples, whereas only 16.1% of controls were positive for HPV. We observed statistically significant differences between breast cancer patients and HPV presence (P = 0.003). HPV type 18 was the most prevalent virus genotype in patients. The expression of P53, RB, BRCA1, and BRCA2 were decreased in patients with HPV-positive breast cancer as compared to HPV-negative breast cancer and healthy controls. (All P-values were less than 0.05). The presence of the HPV was associated with increased inflammatory cytokines (IL-1, IL-6, IL-17, TGF-β, TNF-α, and NF-kB) and tumor progression. Conclusion: The present study demonstrated that HPV infection may implicate in the development of some types of breast cance

    The susceptibility to diabetic retinopathy in type 2 diabetic patients of Iran is not affected by the M55V polymorphism of SUMO4

    No full text
    Introduction: Recent reports showed that the small ubiquitin-like modifier 4 (SUMO4) M55V polymorphism is affected development of type 2 diabetes and its complications such as diabetic nephropathy and retinopathy in some populations. In this regard we intend to investigate the impact of M55V polymorphism of SUMO4 on susceptibility to diabetic retinopathy in the type 2 diabetic patients of Iran. Methods: In current study, the control group had included 100 individuals of type 2 diabetic patients of Iran who have not retinopathy, while the patient group had included 100 individuals of type 2 diabetic patients of Iran suffering from retinopathy. We have matched all the confounding factors between patients and controls. The genotyping method was PCR-RFLP to trace a prevalent single nucleotide polymorphism at codon 55 encoding a substitution of methionine to valine (M55V) specified in the SUMO4 gene. Results: Genotype frequency of AA, AG, and GG of SUMO4 were obtained respectively 52, 30, and 18 in the patient group and 44, 36, and 20 in the control group. The frequencies of alleles A and G of SUMO4 were 67 and 33 in the patients with type 2 diabetes having retinopathy and 62 and 38 in the patients with type 2 diabetes without retinopathy. There genotypic and allelic frequencies of SUMO4 were not significantly (p>0.05) different between the patient and the control groups. Conclusions: The findings of the present study showed no correlation between M55V polymorphism of SUMO4 gene and diabetic retinopathy in type 2 diabetes patients of Iran. However, we emphasize that further studies is necessary to clarify the exact role of M55V polymorphism of SUMO4 in diabetic retinopathy in patients with type 2 diabetes

    Epstein�Barr virus and thyroid cancer: The role of viral expressed proteins

    No full text
    Background: Thyroid cancer is a common endocrine malignancy whose incidence has increased in recent years. Several internal and external risk factors are involved in the development of this cancer, such as infectious agents. Evidence supporting the role of viral infection as an etiology for the invasiveness of thyroid cancer is increasing. The aim of this study was to determine the presence of the Epstein�Barr virus (EBV) and the association between viral gene products and thyroid tumor development. Methods: Fifty-seven thyroid cancer specimens were collected from the same number of patients as well as 18 samples from healthy controls. The presence of the EBV genome and the genotyping was examined by polymerase chain reaction (PCR). Also, an enzyme-linked immunosorbent assay and real-time PCR were used to measure the expression levels of viral and cellular genes. Results: The EBV DNA was detected in 71.9 of the samples, and it was also found that the presence of the EBV was associated with increasing development of thyroid tumor. Conclusion: Our results demonstrated that EBV infection may play a role in the development of thyroid tumor. © 2018 Wiley Periodicals, Inc

    Epstein–Barr virus and thyroid cancer: The role of viral expressed proteins

    No full text
    Background: Thyroid cancer is a common endocrine malignancy whose incidence has increased in recent years. Several internal and external risk factors are involved in the development of this cancer, such as infectious agents. Evidence supporting the role of viral infection as an etiology for the invasiveness of thyroid cancer is increasing. The aim of this study was to determine the presence of the Epstein–Barr virus (EBV) and the association between viral gene products and thyroid tumor development. Methods: Fifty-seven thyroid cancer specimens were collected from the same number of patients as well as 18 samples from healthy controls. The presence of the EBV genome and the genotyping was examined by polymerase chain reaction (PCR). Also, an enzyme-linked immunosorbent assay and real-time PCR were used to measure the expression levels of viral and cellular genes. Results: The EBV DNA was detected in 71.9% of the samples, and it was also found that the presence of the EBV was associated with increasing development of thyroid tumor. Conclusion: Our results demonstrated that EBV infection may play a role in the development of thyroid tumo
    corecore